The next step of neurogenesis in the context of Alzheimer’s disease

被引:0
|
作者
Hamid Reza Moradi
Vahid Hajali
Zabihollah Khaksar
Farzaneh Vafaee
Fatemeh Forouzanfar
Sajad Sahab Negah
机构
[1] Shiraz University,Department of Basic Sciences, School of Veterinary Medicine
[2] Mashhad University of Medical Sciences,Neuroscience Research Center
[3] Society for Brain Mapping and Therapeutics,Shefa Neuroscience Research Center
[4] Iranian Chapter,Department of Neuroscience, Faculty of Medicine
[5] SBMT,undefined
[6] Khatam Alanbia Hospital,undefined
[7] Mashhad University of Medical Sciences,undefined
来源
Molecular Biology Reports | 2021年 / 48卷
关键词
Neurogenesis; Alzheimer’s Disease; Pharmacology; Herbal Medicine; Cognitive Function;
D O I
暂无
中图分类号
学科分类号
摘要
Among different pathological mechanisms, neuronal loss and neurogenesis impairment in the hippocampus play important roles in cognitive decline in Alzheimer’s disease (AD). AD is a progressive and complex neurodegenerative diseases, which is very debilitating. The purpose of this paper is to review recent research into neurogenesis and AD and discuss how pharmacological drugs and herbal active components have impacts on neurogenesis and consequently improve cognitive functions. To date, despite huge research, no effective treatment has been approved for AD. Therefore, an avenue for future research and drug discovery is stimulating adult hippocampal neurogenesis (AHN). Evidence suggests that neurogenesis is regulated by the pharmacological treatment that may be recommended as a part of prophylaxis and therapeutic options for AD. However, the underlying mechanisms of regulating neurogenesis in AD are not well understood. To this point, we highlight to achieve an efficient treatment in AD by manipulating neurogenesis, it’s necessary to target all steps of neurogenesis.
引用
收藏
页码:5647 / 5660
页数:13
相关论文
共 50 条
  • [31] Reduced neurogenesis in human hippocampus with Alzheimer's disease
    Cao, Yan
    Liu, Pan
    Bian, Hongfei
    Jin, Sixuan
    Liu, Jiaqi
    Yu, Ning
    Cui, Huan
    Sun, Fengrun
    Qian, Xiaojing
    Qiu, Wenying
    Ma, Chao
    BRAIN PATHOLOGY, 2024, 34 (03)
  • [32] Promoting Endogenous Neurogenesis as a Treatment for Alzheimer’s Disease
    Qiang Zhang
    Jingyue Liu
    Li Chen
    Ming Zhang
    Molecular Neurobiology, 2023, 60 : 1353 - 1368
  • [33] Of mice and men: neurogenesis, cognition, and Alzheimer's disease
    Lazarov, Orly
    Marr, Robert A.
    FRONTIERS IN AGING NEUROSCIENCE, 2013, 5
  • [34] The role of STEP in Alzheimer's disease
    Kurup, Pradeep
    Zhang, Yongfang
    Venkitaramani, Deepa V.
    Xu, Jian
    Lombroso, Paul J.
    CHANNELS, 2010, 4 (05) : 347 - 350
  • [35] Context Memory in Alzheimer's Disease
    El Haj, Mohamad
    Kessels, Roy P. C.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2013, 3 (01): : 342 - 350
  • [36] Neuropeptides promoting neurogenesis in models of Alzheimer's and Parkinson's disease
    Novak, P.
    Rockenstein, E.
    Mante, M.
    Moessler, H.
    Doppler, E.
    Blanchard, J.
    Adame, A.
    Crews, L.
    Li, B.
    Grundke-Iqbal, I.
    Iqbal, K.
    Masliah, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 354 - 354
  • [37] Abnormalities in neurogenesis in Alzheimer disease
    Grundke-Iqbal, I
    Tatebayashi, Y
    Li, L
    Haque, N
    Iqbal, K
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S563 - S563
  • [38] Next generation therapeutics for Alzheimer's disease
    Bredesen, Dale E.
    John, Varghese
    EMBO MOLECULAR MEDICINE, 2013, 5 (06) : 795 - 798
  • [39] The next steps in curing Alzheimer's disease
    van Leeuwen, Fred W.
    MOLECULAR BIOLOGY OF NEURODEGENERATIVE DISEASES: VISIONS FOR THE FUTURE, PT A, 2019, 168 : 219 - 221
  • [40] Melatonin in Alzheimer’s Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer’s Neuropathology
    Md. Farhad Hossain
    Md. Sahab Uddin
    G. M. Sala Uddin
    Dewan Md. Sumsuzzman
    Md. Siddiqul Islam
    George E. Barreto
    Bijo Mathew
    Ghulam Md Ashraf
    Molecular Neurobiology, 2019, 56 : 8255 - 8276